(Q89014299)
Statements
PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies (English)
Yonghui Sun
Xingwang Zhao
Ning Ding
Hongying Gao
Yue Wu
Yiqing Yang
Meng Zhao
Jinseok Hwang
Yuqin Song